Molecular classification of endometrial cancer by P53 and PTEN pathways

被引：0
|
作者：
Ince, TA [1 ]
Kust, GA [1 ]
Baker, HE [1 ]
Mutter, GL [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2002年 / 15卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
831
引用
收藏
页码：198A / 199A
页数：2
相关论文
共 50 条
  • [31] Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer
    Sakuragi, N
    Watari, H
    Ebina, Y
    Yamamoto, R
    Steiner, E
    Koelbl, H
    Yano, M
    Tada, M
    Moriuchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (04) : 514 - 519
  • [32] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1034 - 1035
  • [33] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1034 - 1035
  • [34] ANALYSIS OF BCL-2, PTEN, P53 AND KI-67 EXPRESSIONS IN ENDOMETRIAL CANCER ARISING FROM ENDOMETRIAL POLYP: PRELIMINARY RESULTS
    Atasoy, L.
    Kuscu, U. E.
    Akilli, H.
    Haberal, A.
    Ayhan, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1019 - 1019
  • [35] Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
    Artandi, SE
    Attardi, LD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) : 881 - 890
  • [36] Using Apparent Diffusion Coefficient (ADC) of Endometrial Cancer MRI to Determine P53 Molecular Subtypes
    Zhang F.
    Wang T.
    Ning Y.
    Li S.
    Chen X.
    Zhang G.
    Zhang H.
    Current Medical Imaging, 2024, 20
  • [37] Progesteron receptor status is a prognostic molecular marker in patients with P53 abnormal endometrioid endometrial cancer
    Omatsu, Kohei
    Chang, Ting-Chang
    Jung, Shih-Ming
    Ueng, Shir-Hwa
    Chang, Wei-Yan
    Lynn, Perera
    Chen, Shu-Shen
    Chou, Hung-Hseh
    Lai, Chyong-Huey
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A160 - A161
  • [38] T-cell Density is Associated with ERG, PTEN and p53 Molecular Status in Primary Prostate Cancer
    Kaur, Harsimar
    Guedes, Liana Benevides
    Lu, Jiayun
    Maldonado, Laneisha
    Reitz, Logan
    Barber, John R.
    Hicks, Jessica L.
    DeMarzo, Angelo
    Joshu, Corinne
    Sfanos, Karen
    Lotan, Tamara L.
    LABORATORY INVESTIGATION, 2018, 98 : 355 - 355
  • [39] T-cell Density is Associated with ERG, PTEN and p53 Molecular Status in Primary Prostate Cancer
    Kaur, Harsimar
    Guedes, Liana Benevides
    Lu, Jiayun
    Maldonado, Laneisha
    Reitz, Logan
    Barber, John R.
    Hicks, Jessica L.
    DeMarzo, Angelo
    Joshu, Corinne
    Sfanos, Karen
    Lotan, Tamara L.
    MODERN PATHOLOGY, 2018, 31 : 355 - 355
  • [40] Clinical Profile and Survival Outcome of Endometrial Cancer with p53 Mutation
    Tresa, Anila
    Sambasivan, Suchetha
    Rema, P.
    Dinesh, Dhanya
    Sivaranjith, J.
    Nair, Sindhu P.
    Mathew, Aleyamma
    Ammu, J., V
    Kumar, Aswin
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 13 (03) : 580 - 586
12345